Grabarczyk, M.; Szychowska, A.; Kozłowski, S.; Sipowicz, K.; Pietras, T.; Kosmalski, M.; Różycka-Kosmalska, M.
Intranasally Administered Insulin as Neuromodulating Factor and Medication in Treatment of Neuropsychiatric Disorders—Current Findings from Clinical Trials. Sci. Pharm. 2025, 93, 52.
https://doi.org/10.3390/scipharm93040052
AMA Style
Grabarczyk M, Szychowska A, Kozłowski S, Sipowicz K, Pietras T, Kosmalski M, Różycka-Kosmalska M.
Intranasally Administered Insulin as Neuromodulating Factor and Medication in Treatment of Neuropsychiatric Disorders—Current Findings from Clinical Trials. Scientia Pharmaceutica. 2025; 93(4):52.
https://doi.org/10.3390/scipharm93040052
Chicago/Turabian Style
Grabarczyk, Mikołaj, Aleksandra Szychowska, Sebastian Kozłowski, Kasper Sipowicz, Tadeusz Pietras, Marcin Kosmalski, and Monika Różycka-Kosmalska.
2025. "Intranasally Administered Insulin as Neuromodulating Factor and Medication in Treatment of Neuropsychiatric Disorders—Current Findings from Clinical Trials" Scientia Pharmaceutica 93, no. 4: 52.
https://doi.org/10.3390/scipharm93040052
APA Style
Grabarczyk, M., Szychowska, A., Kozłowski, S., Sipowicz, K., Pietras, T., Kosmalski, M., & Różycka-Kosmalska, M.
(2025). Intranasally Administered Insulin as Neuromodulating Factor and Medication in Treatment of Neuropsychiatric Disorders—Current Findings from Clinical Trials. Scientia Pharmaceutica, 93(4), 52.
https://doi.org/10.3390/scipharm93040052
